ACCOUNTS - Final Accounts preparation

FOCUS ON LIFE SCIENCES LIMITED - Company Information

Caseware UK (AP4) 2022.0.179 2022.0.179 2022-03-31130864862022-03-312020-12-17falsefalsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13086486 2020-12-16 13086486 2020-12-17 2022-03-31 13086486 2022-03-31 13086486 1 2020-12-17 2022-03-31 13086486 d:Director1 2020-12-17 2022-03-31 13086486 c:CurrentFinancialInstruments 2022-03-31 13086486 c:CurrentFinancialInstruments c:WithinOneYear 2022-03-31 13086486 c:ShareCapital 2022-03-31 13086486 c:RetainedEarningsAccumulatedLosses 2022-03-31 13086486 d:OrdinaryShareClass1 2020-12-17 2022-03-31 13086486 d:OrdinaryShareClass1 2022-03-31 13086486 d:FRS102 2020-12-17 2022-03-31 13086486 d:AuditExempt-NoAccountantsReport 2020-12-17 2022-03-31 13086486 d:FullAccounts 2020-12-17 2022-03-31 13086486 d:PrivateLimitedCompanyLtd 2020-12-17 2022-03-31 13086486 d:PublicLimitedCompanyPLCNotQuotedOnAnyExchange 2020-12-17 2022-03-31 xbrli:shares iso4217:GBP xbrli:pure

Focus on Life Sciences Limited

Registered number: 13086486

Information for
filing with Registrar

For the period ended 31 March 2022

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

REGISTERED NUMBER: 13086486

STATEMENT OF FINANCIAL POSITION

AS AT 31 MARCH 2022

		31 March 2022
Note		£


Current assets
Debtors: amounts falling due within one year	4	214,257
Cash at bank and in hand		25,290
		239,547
Creditors: amounts falling due within one year	5	(249,465)
Net current liabilities			(9,918)

Net liabilities			(9,918)

Capital and reserves
Called up share capital	6	100
Profit and loss account		(10,018)
Total equity		(9,918)

- 1 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

REGISTERED NUMBER: 13086486

STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 MARCH 2022

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

L G Gordon

Director

Date: 22 August 2023

The notes on pages 3 to 8 form part of these financial statements.

- 2 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2022

1.	General information

Focus On Life Sciences Limited is a private company limited by shares incorporated in England and Wales. The registered number of the company is 13086486. The address of its registered office is 1st Floor Queensway House, Queens Road, Brighton, England, BN1 3XF.
The principal activity of the company is to provide recruitment services to professional industries.
The company was incorporated on 17 December 2020. The financial statements are for the first financial period ended 31 March 2022. Therefore the results covered are for more than twelve months.
On 10 January 2022 the company extended its accounting reference date from 31 December 2021 to 31 March 2022.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
These financial statements have been prepared in Pound Sterling as this is the company's functional currency and the currency in which the company undertakes its major financial transactions and is rounded to the nearest pound.

The following principal accounting policies have been applied:

2.2

Going concern

The financial statements are prepared on a going concern basis. The company remains assured of the financial support by the parent company. The directors have received confirmation that the parent company will continue to support the company and provide it with adequate funds when necessary to enable it to meet its debts as they fall due for a period of at least twelve months from the date of these financial statements. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.

- 3 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2022

2.Accounting policies (continued)

2.3

Foreign currency translation

Functional and presentation currency

The company's functional and presentation currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.

All other foreign exchange gains and losses are presented in the Statement of comprehensive income within 'administrative expenses'.

2.4

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of turnover can be measured reliably;

∙it is probable that the company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

- 4 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2022

2.Accounting policies (continued)

2.6

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the company in independently administered funds.

2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.10

Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of
financial assets and liabilities like trade and other accounts receivable and payable.
Financial assets
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is identified, an impairment loss is recognised in profit or loss.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and its recoverable amount, which is an estimate of the amount that the company would receive for the asset if it were to be sold at the reporting date.

- 5 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2022

2.Accounting policies (continued)

2.10

Financial instruments (continued)

Financial liabilities
Basic financial liabilities, including trade and other payables are initially recognised at transaction price, unless the arrangement constitute a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a rate of interest.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payables are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transactions price and subsequently measured at amortised costs.
Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Employees

The average monthly number of employees, including the directors, during the period was 4.

4.	Debtors: Amounts falling due within one year

					31 March 2022
					£


	Trade debtors	41,835
	Amounts owed by group undertakings	99,097
	Other debtors	7,930
	Prepayments and accrued income	65,395
		214,257

Amounts owed by group undertakings are unsecured, interest-free and payable on demand.

- 6 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2022

5.	Creditors: Amounts falling due within one year
		31 March 2022
		£

	Bank overdrafts	13,234
	Trade creditors	14,904
	Amounts owed to group undertakings	167,989
	Other taxation and social security	2,948
	Other creditors	1,471
	Accruals	48,919
		249,465

Amounts owed to group undertakings are unsecured, interest-free and repayable on demand.

6.	Called up share capital
		31 March 2022
		£

		Allotted, called up and fully paid

		100 ordinary shares of £1 each	100

The company has one class of ordinary shares; each share has attached to it full voting, dividend and capital distribution rights.

7.	Contingent liabilities

The group factors some of its trade debtors. The factoring company holds a floating charge over the assets of the group and a fixed charge over the factored debts. Both charges were created on 4 February 2016.

8.	Pension commitments

The company makes contributions into defined contribution pensions schemes on behalf of certain employees. The assets of the schemes are held separately from those of the company in independently administered funds. At the period end, an amount of £1,471 was payable to the scheme and is included within other creditors.

- 7 -

13086486

31 March 2022

FOCUS ON LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MARCH 2022

9.	Related party transactions
	The company is has taken advantage of the exemption from disclosing related party transactions undertaken between wholly owned members of the group that have been concluded under normal market conditions.

10.	Post balance sheet events

On the 3 August 2022 the company registered a fixed charge over the properties of the company with Close Brothers Limited (The "Security Trustee"). The factoring company holds a fixed charge over the factored debts.

11.	Controlling party

The immediate and ultimate parent company is Focus Cloud Limited, a company incorporated in England and Wales. Focus Cloud Limited is the parent undertaking of the smallest and largest group which consolidates the financial information of the company. Copies of the consolidated financial statements may be obtained from its registered office address, 1st Floor Queensberry House, Queens Road, Brighton, England, BN1 3XF.
The ultimate controlling party is L G Gordon by virtue of his shareholding in Focus Cloud Limited.

- 8 -